To examine the possible association between the vascular complications of diabetes and changes in pulmonary function, we performed pulmonary function tests including assessment of the diffusing capacity (%DLco) in 80 patients with non-insulin-dependent diabetes mellitus (45 males and 35 females) without overt lung or heart disease. The mean age of the subjects was 57.9 years and the mean duration of diabetes was 10.8 years. The %DLco decreased significantly as the duration of diabetes increased (r = -0.38, p < 0.01), and the same relationship was also observed in non-smoking subjects (N = 37). The reduction in %DLco was greater in patients with diabetic microangiopathy (especially nephropathy) and in those treated with insulin. Other pulmonary function tests (%VC, FEV^o, PaO2 and PaCO2) showed no relationship to the duration of diabetes, the degree of microangiopathy or the type of treatment. These results suggest that diabetic microangiopathy may play an important role in the decrease of %DLco.
Introduction
It is well known that diabetes mellitus is associated with an increased susceptibility to infections. With the widespread use of insulin and the advent of newer antimicrobial agents, deaths due to infection have declined considerably among diabetic patients in recent years (1) . However, the clinical significance of infections has not yet diminished (2) . Pre-existing pulmonary function disorders are now suspected to be one of the risk factors for respiratory infections in diabetics (3) . In this regard, studies of the reduction of the diffusing capacity, forced vital capacity and forced expiratory volume in one second (FEV1 0) have been reported (4) (5) (6) (7) . These studies have been based on the comparison of the pulmonary function of patients with insulin-dependent diabetes mellitus (IDDM) with that of normal subjects. Few studies however, have focused on the relationship between pulmonary function and the duration of diabetes or the presence of diabetic vascular complications in patients with non-insulin-dependent diabetes mellitus (NIDDM). Accordingly, in this study NIDDM patients admitted for glycemic control and education of diabetes underwent pulmonary function tests, including measurement of the diffusing capacity. The possible association between vascular complications of NIDDM and changes in pul monary function was examined.
Subjects and Methods
The subjects consisted of 80 patients (45 men and 35 women) with NIDDM, none of whom had overt lung or heart disease. None of these subjects had sustained complaints of coughing, sputum or dyspnea (Table 1) . Spirography, arterial blood gas analysis, and measure ments of the pulmonary diffusing capacity were performed on each subject. We then investigated the relationship between the results of pulmonary function tests and the duration of diabetes, type of treatment, presence of diabetic complications and various other factors. Vital capacity (VC), FEV1 0 and carbon monoxide diffusing capacity (DLco) were expressed as a percentage of the corresponding values obtained from age-matched normal subjects (8, 9) . The presence of diabetic microangiopathy was defined PWV: aortic pulse wave velocity as follows: retinopathy was diagnosed by fundoscopic examination by ophthalmologists, nephropathy was diagnosed when proteinuria was present in 2 consecutive examinations or the serum creatinine value exceeded 2mg/dl, and neuropathy was diagnosed by subjective symptoms or physical examinations. Aortic pulse wave velocity (PWV), as an index for arteriosclerosis, was determined as previously reported (10) . Statistical analy sis was carried out using Student's t-tests and linear correlation analysis. Results
Duration of diabetes
%DLco was negatively correlated with the duration of diabetes (r= -0.39, p<0.01, Fig. 1 ). Other pul monary function tests including %VC, FEV1-0 or PaO2 did not correlate with the duration of diabetes ( Table 2) . As smoking is a well-known factor affecting pulmonary function (ll), same procedures were conducted exclu ding 43 smokers. It was found that %DLco still corre- All cases (n = 80) Nonsmokers (n = 37) lated negatively with the duration of diabetes (r = -0.37, p < 0.05). There was no significant difference between smokers and non-smokers in mean age, body surface area or the duration of diabetes.
Diabetic microangiopathy
Patients with diabetic microangiopathy had a slight decrease in %VC compared to patients without micro angiopathy. No relationship was found between diabetic microangiopathy and FEVi.0% , PaO2 or PaCO2 (Table  3) . Patients with diabetic microangiopathy had a de creased %DLco compared to patients without micro angiopathy. In addition, as shown in Fig. 2 , %DLco in patients with nephropathy was significantly lower than in those without nephropathy (72.0±21.8% vs 82.3 ± 13.1%, p<0.05). The duration of diabetes was 14.4 years for subjects with nephropathy and 9.7 years without nephropathy (p < 0.01). There was no significant difference in the hemoglobin levels between subjects with or without nephropathy.
Treatment of diabetes
The relationship between the treatment of diabetes with insulin or with oral hypoglycemic agents and/or diet, and the results of the pulmonary function tests was also investigated. Patients treated with insulin had a significant decrease in %DLco compared to patients treated with others drugs (p<0.05, Table 4 ). No re lationship was found between the type of treatment and 4. Macroangiopathy Our previous study (10) indicated that PWV is in creased in patients with diabetic microangiopathy, sug gesting a possible association between macroangiopathy and microangiopathy. Here, the %VC and PaO2 showed (mean ± SD) insulin: patients treated with insulin others: patients treated with hypoglycemic agents and/or diet a negative correlation with the PWV values (p < 0.05, Table 5 ). There was a weak negative relationship between PWV and %DLco (p = 0.05). No correlation was found between PWV and FEVi.0% or PaCO2. In addition, PaO2 was negatively correlated with APWV, which is the difference betweeen PWV values in diabetic patients and the mean PWV values for normal age-matched subjects (r = -0.40, p <0.01, Fig. 3 ). The relationship was not significant between APWV and %VC, FEVx.0%, %DLco or PaCO2.
Discussion
Previous studies concerning pulmonary function Table 5 . Correlation between Aortic Pulse Wave Velocity and Pulmonary Function tests APWV, the difference between the PWV of the patients and the mean PWV of age-matched subjects abnormalities in diabetics have mainly dealt with IDDM patients (4-7), and only a few studies have been con ducted on NIDDM patients. The present study indicates that several types of pulmonary function disorders exist in NIDDM patients. First, pulmonary diffusing capacity, as determined by %DLco, was found to correlate negatively with the duration of diabetes (Table 2 and Fig. 1 ). Furthermore, %DLco was reduced in patients with diabetic micro angiopathy ( Table 3 and Fig. 2 ). Asanuma et al (3) and Sandier et al (12) have reported that as the duration of diabetes is increased, the pulmonary diffusing capacity is decreased. Asanuma et al also found that patients with diabetic retinopathy have a decreased %DLco compared to patients without retinopathy, but Sandier et al found no relationship between diabetic vascular complications and pulmonary diffusing capacity. Because Asanuma et al studied diabetics of a mean age of 50 years while Sandier et al studied much younger patients with IDDM, this discrepancy in their results seems to be attributable to the differing populations of subjects investigated. Uchida and co-workers (13) studied ventilation perfusion scintigrams in diabetic subjects. They ob served a decreased pulmonary diffusing capacity in patients with a perfusion defect. As these patients had a longer duration of diabetes and higher incidence of retinopathy, the existence of pulmonary microangiopathy was suggested. These results indicate that, as one mani festation of diabetic microangiopathy, % DLco is reduced by microangiopathic involvement of pulmonary vessels leading to ventilation-perfusion inequalities. In the pre sent results, insulin-treated subjects had significantly lower %DLco values compared to those treated with other vehicles (Table 4) . This is partly explained by the fact that insulin-treated subjects had a longer duration of diabetes compared to the other subjects (12.7 years and 9.7 years, respectively). Secondly, with an increase in PWV values, it was found that PaO2 values were decreased (Table 5 and Fig. 3 ). PWV is considered to be an indicator of macro angiopathy. Sugawara et al (14) explained that 1) an increase in the diffusion distance due to thickening of the pulmonary capillary basement membrane, 2) a de crease in alveolar-capillary matrix, and 3) ventilation perfusion inequalities due to a decrease in surfactant concomitantly lead to a decreased diffusing capacity, and secondarily to lower PaO2 values. In this study, we could not observe a correlation between PaO2 and the duration of diabetes or %DLco. Therefore, we suspect that the mechanism which contributes to decreased PaO2 might be different from that causing decreased %DLco (possibly ventilation-perfusion inequalities) in diabetic subjects. Further investigation with a larger group is necessary to clarify the relationship of macroangiopathy and decreased PaO2.
In the present study, there was no relationship be tween HbAlc levels at the time of pulmonary function measurements and the results of pulmonary function tests (data not shown). Because HbAlc levels are known as indicators of glycemic control for a short period of 1-2 months, it is not adequate to conclude that the plasma glucose level is not related to the decreased %DLco. In fact, Lange et al (15) , who performed mul tiple regression analysis of their data, suggested that an elevated plasma glucose concentration is one of the risk factors for a decrease in forced vital capacity and FEVx 0. In future, it seems necessary to repeat pulmonary function tests and to assess the changes of pulmonary function among the same subjects, including the investi gation of the risk factors for such changes in the tests. Over a long observation course, the relationship between the plasma glucose concentration and the pulmonary function can be elucidated.
C onclusions 1. Pulmonary diffusing capacity, as determined by %DLco, was found to be negatively correlated with the duration of diabetes. In addition, %DLco was lower in patients with diabetic microangiopathy (nephropathy) or those treated with insulin. These results indicate that decreased pulmonary diffusing capacity may develop as one manifestation of diabetic microangiopathy.
2. Values of PaO2 were found to correlate negatively with PWV, whereas no definite relationship was observed between PaO2 and the duration of diabetes or %DLco. A part of this study was presented at the 27th General Meeting of the Chugoku-Shikoku District of the Japan Diabetes Society (October 1989, Matsue) and at the
